Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Finland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20113
20122
20143
20151
20181
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated6
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
AbbVie2
Novartis Pharmaceuticals2
Sanofi2
Biogen1
Bristol-Myers Squibb1
Celcuity Inc1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Institut de Recherches Internationales Servier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis18
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Renal Cell2
Brain Neoplasms1
Carcinoma, Medullary1
Colorectal Neoplasms1
Endocrine Gland Neoplasms1
Endometrial Neoplasms1
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.